AI-generated summary
The authors studied whether adding supravascular laser exposure to standard treatment helps patients with atherosclerosis obliterans affecting smaller leg blood vessels. The abstract reports that 32 patients received the laser treatment in addition to traditional therapy, while a control group received no laser therapy. The authors state that the efficiency of this combined approach was demonstrated and that the noninvasive laser method was validated.
- Participants
- 32
- Who or what was studied
- Patients with atherosclerosis obliterans with distal vascular lesions of the lower extremities
- Limits stated in the abstract
- The abstract does not report the control group size, outcome measures, wavelengths, or statistical details, so the strength of the reported efficacy cannot be assessed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.